A HSP-TLR-Wnt5a Paracrine Signaling Axis Drives CXCR2 Ligand Recruitment of Myeloid-derived Suppressor Cells and Represents a Novel Adaptive Resistance Mechanism to Anti-PD-1 Antibody Therapy.
Publication
, Conference
Hanks, BA
Published in: https://jitc.biomedcentral.com/track/pdf/10.1186/s40425-017-0288-4?site=jitc.biomedcentral.com
Duke Scholars
Published In
https://jitc.biomedcentral.com/track/pdf/10.1186/s40425-017-0288-4?site=jitc.biomedcentral.com
Location
National Harbor, Maryland
Conference Name
2017 SITC Annual Meeting
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Hanks, B. A. (n.d.). A HSP-TLR-Wnt5a Paracrine Signaling Axis Drives CXCR2 Ligand Recruitment of Myeloid-derived Suppressor Cells and Represents a Novel Adaptive Resistance Mechanism to Anti-PD-1 Antibody Therapy. In https://jitc.biomedcentral.com/track/pdf/10.1186/s40425-017-0288-4?site=jitc.biomedcentral.com. National Harbor, Maryland.
Hanks, B. A. “A HSP-TLR-Wnt5a Paracrine Signaling Axis Drives CXCR2 Ligand Recruitment of Myeloid-derived Suppressor Cells and Represents a Novel Adaptive Resistance Mechanism to Anti-PD-1 Antibody Therapy.” In Https://Jitc.Biomedcentral.Com/Track/Pdf/10.1186/S40425-017-0288-4?Site=jitc.Biomedcentral.Com, n.d.
Hanks BA. A HSP-TLR-Wnt5a Paracrine Signaling Axis Drives CXCR2 Ligand Recruitment of Myeloid-derived Suppressor Cells and Represents a Novel Adaptive Resistance Mechanism to Anti-PD-1 Antibody Therapy. In: https://jitc.biomedcentral.com/track/pdf/101186/s40425-017-0288-4?site=jitc.biomedcentral.com.
Hanks, B. A. “A HSP-TLR-Wnt5a Paracrine Signaling Axis Drives CXCR2 Ligand Recruitment of Myeloid-derived Suppressor Cells and Represents a Novel Adaptive Resistance Mechanism to Anti-PD-1 Antibody Therapy.” Https://Jitc.Biomedcentral.Com/Track/Pdf/10.1186/S40425-017-0288-4?Site=jitc.Biomedcentral.Com.
Hanks BA. A HSP-TLR-Wnt5a Paracrine Signaling Axis Drives CXCR2 Ligand Recruitment of Myeloid-derived Suppressor Cells and Represents a Novel Adaptive Resistance Mechanism to Anti-PD-1 Antibody Therapy. https://jitc.biomedcentral.com/track/pdf/101186/s40425-017-0288-4?site=jitc.biomedcentral.com.
Published In
https://jitc.biomedcentral.com/track/pdf/10.1186/s40425-017-0288-4?site=jitc.biomedcentral.com
Location
National Harbor, Maryland
Conference Name
2017 SITC Annual Meeting
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3204 Immunology